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Complement expression in the retina is not influenced by shortterm pressure elevation
Konstantin Astafurov,1 Cecilia Q. Dong,2 Lampros Panagis,1 Gautam Kamthan,3 Lizhen Ren,1 Anna
Rozenboym,4 Tarique D. Perera,5 Jeremy D. Coplan,6 John Danias1,2
Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY; 2Department of Ophthalmology, SUNY Downstate
Medical Center, Brooklyn, NY; 3Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY; 4Department of
Biological Sciences, CUNY Kingsborough Community College, Brooklyn, NY; 5Department of Psychiatry, Columbia University
Medical Center and New York State Psychiatric Institute, New York, NY; 6Department of Psychiatry, SUNY Downstate Medical
Center, Brooklyn, NY
1

Purpose: To determine whether short-term pressure elevation affects complement gene expression in the retina in vitro
and in vivo.
Methods: Muller cell (TR-MUL5) cultures and organotypic retinal cultures from adult mice and monkeys were subjected to either 24-h or 72-h of pressure at 0, 15, 30, and 45 mmHg above ambient. C57BL/6 mice were subjected to
microbead-induced intraocular pressure (IOP) elevation for 7 days. RNA and protein were extracted and used for analysis
of expression levels of complement component genes and complement component 1, q subcomponent (C1q) and complement factor H (CFH) immunoblotting.
Results: mRNA levels of complement genes and C1q protein levels in Muller cell cultures remained the same for all
pressure levels after exposure for either 24 or 72 h. In primate and murine organotypic cultures, pressure elevation
did not produce changes in complement gene expression or C1q and CFH protein levels at either the 24-h or 72-h time
points. Pressure-related glial fibrillary acidic protein (GFAP) mRNA expression changes were detected in primate retinal
organotypic cultures (analysis of variance [ANOVA]; p<0.05). mRNA expression of several other genes changed as a
result of time in culture. Eyes subjected to microbead-induced IOP elevation had no differences in mRNA expression of
complement genes and C1q protein levels (ANOVA; p>0.05 for both) with contralateral control and naïve control eyes.
Conclusions: Short-term elevation of pressure in vitro as well as short-term (1 week) IOP elevation in vivo does not
seem to dramatically alter complement system gene expression in the retina. Prolonged expression to elevated pressure
may be necessary to affect the complement system expression.

by forming the terminal complement complex (TCC) [8,9].
The complement system comprises several dozen proteins
that are synthesized mainly in the liver and circulate in the
blood stream; some of the complement components can also
be found on cell membranes. The circulating complement
proteins do not cross the blood–brain and the blood–retina
barriers because of their large size. To provide local protection, they are synthesized locally within the central nervous
system (CNS). Several of the complement proteins, including
complement component 1, q subcomponent (C1q) and complement component 3 (C3), have been shown to be expressed in
the retina under normal conditions, albeit at low levels [4,10].

High intraocular pressure (IOP) is an important risk
factor for both the development and progression of glaucoma.
In experimental animal models [1] as well as in humans [2]
exposure to elevated IOP correlates with retinal ganglion
cell (RGC) loss and optic nerve (ON) degeneration. In fact,
lowering IOP is currently the only therapeutic means of
slowing or halting the disease process.
Complement upregulation has been reported as an early
event in the development of glaucoma. Studies in human
glaucomatous tissue [3,4] and experimental animal models
[5-7] have shown that complement system components are
upregulated in the retina in both early and late stages of the
disease.

Locally produced complement components in the CNS
may have additional roles besides their direct immunological
functions. Recent studies have suggested that complement
may participate in normal developmental processes, such
as pruning of synapses [11] and other developmental and
degenerative processes [9,12], implicating it in diseases such
as schizophrenia [13,14], Alzheimer disease [15], Parkinson
disease [16], and glaucoma [17].

The complement system is part of the innate immune
system. Its functions are to opsonize antigens, recruit
macrophages, and cause the lysis of bacterial pathogens
Correspondence to: Konstantin Astafurov, Department of Cell
Biology, Box 5, SUNY Downstate Medical Center, 450 Clarkson
Ave, Brooklyn, NY 11203; Phone: (718) 270-8049; FAX: (718) 2707678; email: Konstantin.Astafurov@downstate.edu
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Given the central role of IOP elevation in glaucomatous
pathophysiology and the role of the complement system in the
same process, we examined whether short-term increases in
pressure affect complement expression in an immortalized
Muller cell line and organotypic retinal cultures in vitro. We
also examined whether complement is affected by relatively
short (1 week) IOP elevation in vivo in a microbead-induced
model of ocular hypertension in mice.
METHODS
Cell cultures: Conditionally immortalized cell line of Muller
cells (TR-MUL5; originally described in [18]) were used and
maintained in culture as previously described [19]. The cell
line was kindly provided by Dr. Thomas Weber (Mount Sinai
School of Medicine, New York, NY).
TR-MUL5 cells were kept at 34 °C in high glucose
Dulbecco’s Modified Eagle Medium (DMEM; Gibco, Invitrogen, Carlsbad, CA), 10% heat-inactivated fetal bovine
serum (FBS; Gibco, Invitrogen), penicillin and streptomycin
(Gibco, Invitrogen) in noncoated culture flasks. Cells at
approximately 30% confluence were used for pressurization.
Immediately before pressurization the cells were transferred
to serum-free media and kept there for the duration of the
experiment.
Animals: All procedures were performed in accordance with
the Association for Research in Vision and Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vision
Research. All animal protocols in the current study and
previous studies described were approved by the Institutional
Animal Care and Use Committee (IACUC) committee of
SUNY Downstate Medical Center (New York, NY).
A group of 3- to 5-month-old C57BL/6 mice from the
colony that we maintain (SUNY Downstate Medical Center)
was used in the experiments. Mice were kept in a 12 h:12 h
light–dark cycle and fed ad libitum.
Retinas from four normally reared young adult (6–9years old) female bonnet macaque (Macaca radiata) monkeys
were obtained immediately after sacrifice. These monkeys
were part of the control (untreated) group of an unrelated
experiment (to study whether antidepressants affect neurogenesis), which was approved by a separate IACUC protocol.
All monkeys were housed in accordance with the guidelines
of the IACUC in a social pen containing eight subjects. For
the duration of 10 weeks before sacrifice, the animals were
sedated with ketamine once a week to receive a placebo via
a gastric tube. No other experimental manipulations were
performed. All monkeys received food and water ad libitum
for the duration of the study. Prior to sacrifice, monkeys were

© 2014 Molecular Vision

anesthetized to a surgical depth with sodium pentobarbital
(12.5 mg/kg intravenously [IV]) with the goal of maintaining
a deep sedation and minimizing discomfort. The depth of
anesthesia was confirmed as indicated by the absence of pain
reflexes, which was assessed by compressing the tail and
orbital fissure, and the absence of deep tendon reflexes of the
knee. The heart was exposed and a cannula inserted through
an incision in the left ventricle into the ascending aorta and
secured with a Babcock clamp. The descending aorta was
clamped with a hemostat and the right atrium incised. Using
a peristaltic pump, cold saline was infused for 10 min to clear
blood vessels.
Retinal organotypic cultures: Mouse retinal organotypic
cultures were prepared from 3−5-month-old (n=40) C57BL/6
mice as previously described [20]. Briefly, animals were anesthetized using ketamine (400 mg/kg) and xylazine (80 mg/
kg), and after cervical dislocation the eyes were immediately
enucleated. The retinas were removed under sterile conditions
in ice-cold Hank’s balanced salt solution (HBSS; Fisher, Pittsburgh PA). Relaxing incisions were made to create flatmounts
that were placed in cell culture inserts (see below).
Primate organotypic cultures were similarly prepared
after sacrifice following transcardial perfusion with ice-cold
saline solution for 10 min. Immediately following the perfusion, eyes were enucleated and quickly dissected under sterile
conditions in ice-cold HBSS. Four punches were made in
each retina with a disposable skin biopsy punch (3 mm), one
from each quadrant at the center of the quadrant between the
optic nerve head and the edge of the retina.
Explants were mounted on cell culture inserts (BD
Biosciences, San Jose, CA) with an 8-μm pore size and
cultured overnight in N-2 (Gibco, Invitrogen), B-27 (Gibco,
Invitrogen), and L-glutamine (Gibco, Invitrogen)-supplemented neurobasal medium (Gibco, Invitrogen), at 34 °C in
24-well plates (BD Biosciences). The following day, fresh
medium was added to the cultures immediately before pressurization. After pressurization, the retinal cultures were
immersed in Trizol reagent (Invitrogen, Carlsbad, CA) for
RNA and protein extraction.
Pressure elevation: The cells and organotypic retinal cultures
were subjected to different levels of pressure in a set of four
polycarbonate pressure chambers that were kept in an incubator at 34 °C for either 24 or 72 h. Pressure was adjusted
to 15 (±3) mmHg, 30 (±3) mmHg, and 45 (±3) mmHg above
ambient in three of the chambers, while the fourth chamber
was maintained at ambient pressure. Pressure was regulated
with a custom-made active feedback electronic system that
injected a mixture of 95% air/5% CO2 until the desired pressure was reached and maintained it with short bursts of gas.
141
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Pressure and temperature was continuously monitored and
recorded in each chamber for the duration of the experiment
by an in-house built data logger; data were downloaded to
a personal computer for evaluation. All pressure exposure
experiments were performed at least in triplicate for cells and
quadruplicate for organotypic retinal cultures at each pressure level. Figure 1 shows a typical graph of pressure and
temperature during a 72-h experiment.
Intraocular pressure elevation in vivo: IOP elevation was
induced in one eye of sixteen 3-month-old male C57BL/6
mice by injection of 10-µm-diameter polystyrene beads
(Invitrogen) as described previously [21]. Briefly, the animals
were anesthetized as above, a small incision was made with
a number 30G needle, and a pulled glass micropipette was
used to inject 1–2 μl of the polystyrene beads into the anterior
chamber (AC) of one eye. The contralateral eye remained
uninjected and served as control. The animals were allowed
to survive for 7 days, after which they were anesthetized as
above, perfused intracardially with PBS (0.1 M, 137 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH
7.4), and the retinas were dissected out. In all animals baseline IOP was measured before treatment. After treatment, IOP
was repeatedly measured and recorded every 2 days (totaling
three times during the 7-day interval) using a prototype
rebound tonometer as previously described [22]. Briefly, IOP
was measured in awake, nonsedated mice that were restrained
in a custom made restrainer that allows measurement of IOP
without causing an increase in intrathoracic pressure. After
mice were put in the restrainer, tetracaine 0.5% was applied
to each eye prior to IOP measurements. Five measurements
were taken from each eye and averaged; IOP was calculated using the tonometer calibration formula as previously
described [22]. Only animals that demonstrated elevated IOP
after the intraocular bead injection (n=10) were used in the
experiments. Nine eyes from a separate group of untreated
3-month-old male mice (n=7) served as a naïve control group.
Cumulative IOP exposure was calculated as a sum of the
products of a measured IOP value on a particular day and the
number of days since the last IOP measurement. Peak IOP
was defined as the highest IOP value of all measurements
from one eye. Average IOP was calculated as the average of
the three IOP values during the 7-day interval.
Real-time quantitative PCR: RNA was extracted from cells,
retinal explants, and mouse retinas from sacrificed mice
using Trizol reagent (Invitrogen) according to the manufacturer’s instructions. Cells, retinal explants, and mouse retinas
from sacrificed mice were homogenized using a drive motor
homogenizer Tissumizer SDT 181 (Tekmar, Cincinnati, OH)
and total RNA was isolated using Trizol reagent (Invitrogen)

Figure 1. Typical pressure and temperature graph of a 72-h pressurization experiment. The four chambers were maintained at 0, 15,
33, and 46 mmHg while temperature was 34.5 °C.

according to the manufacturer’s instructions. The RNA
was precipitated with isopropanol, washed in 70% ethanol,
and column purified (RNAeasy mini kit; Qiagen, Valencia,
CA). RNA quality was assessed by the 260/280 ratio using
a Nanodrop ND-1000 spectrophotometer (Nanodrop Technologies; Wilmington, DE). It was then reverse transcribed
to cDNA with a random primer as per the manufacturer’s
instructions (Quantitect; Qiagen). 1000 ng of isolated total
RNA was then reverse transcribed to cDNA using random
hexamer primers following the manufacturer’s instructions
(Quantitect; Qiagen). cDNA was processed for real-time
quantitative PCR (RT-qPCR) with Power SYBR Green
master mix (Applied Biosystems, Carlsbad, CA or Biobasic,
Canada) and gene-specific primers. RT-qPCR was performed
for the following mouse genes (gene name followed by
GenBank accession number in parenthesis): complement
component 1, sub component q (C1qbp; NM_007573.2),
complement component 2 (C2; NM_013484.2), complement component 4B (C4b; NM_009780.2), complement
factor H (CFH; NM_009888.3), thymus cell antigen 1,
theta (Thy1; NM_009382.3), synuclein gamma (Sncg;
NM_011430.2), and GFAP (NM_010277.3); RT-PCR was
also performed for the following primate genes (gene name
followed by GenBank accession number in parenthesis):
C1qb (XM_001083650.2), CFH (XM_001111875.2), CD46
antigen, complement regulatory protein (CD46; AB172248.1),
complement factor properdin (CFP; JU473400.1), complement regulator complement receptor 1-related gene/proteiny (CRRY; XM_002801945.1), decay accelerating factor for
complement (DAF; XM_001112168.2), complement factor I
(CFI; XM_001087512), serpin peptidase inhibitor, clade G
(C1 inhibitor), member 1 (SERPING1; NC_007871.1), Thy1
(NM_001042638), and GFAP (XM_001102095) genes. All
samples were run in triplicate and were analyzed on the
Applied Biosystems 7900HT Fast Real-Time PCR System.
Statistical analysis was performed using the delta-delta
threshold cycle (Ct) method [23] after normalization using
the mouse ribosomal protein S11 (RPS11) gene (GenBank
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accession number NM_013725.4) and primate RPS11 gene
(GenBank accession number NM_001195754.1). Outliers
were removed using Grubbs’ test [24].
Protein immunoblotting: Proteins were extracted from the
organic phase of Trizol by dialyzing against three changes of
0.1% sodium dodecyl sulfate (SDS) at 4 °C for 48 h as previously described [25]. Protease inhibitors were added, and the
samples were stored at −80 °C until used. Similarly, protein
in the cell culture media was dialyzed as above and stored at
−80 °C. Protein samples were concentrated using Amicon
centrifugal filters (Millipore, Billerica, MA), diluted in
Laemmli sample buffer (BioRad, Hercules, CA), separated in
a 4%–20% SDS– polyacrylamide gel electrophoresis (PAGE)
gel (Bio-Rad, Hercules, CA), and transferred to polyvinylidene fluoride (PVDF) membranes. The membranes were then
blocked (Superblock; Thermo Fisher Scientific, Rockford, IL)
and incubated with either a mouse monoclonal anti-C1q antibody (Abcam, Cambridge, MA; 1:2,000, overnight at 4 °C)
or a goat polyclonal anti-CFH antibody (1:3,000, overnight
at 4 °C; Quidel, catalog# A312; San Diego, CA), followed
by incubation with a horseradish peroxidase-conjugated
secondary antibody (Jackson Immunoresearch, West Grove,
PA) for 2 h at room temperature. A rabbit anti-β-actin-specific
antibody (1:5,000, overnight at 4 °C; Abcam) was used to
detect β-actin, which served as a loading control.
Antibody binding was visualized with a chemiluminescence kit (ECL; Pierce, Rockford, IL) on an image station
(Kodak 440CF; Kodak, Boston, MA) and quantified with
ImageJ image-analysis software (developed by Wayne
Rasband, National Institutes of Health, Bethesda, MD). For
C1q, the sum of the normalized integrated density of all the
bands was used for quantification.
Statistical analysis: The difference between Ct values of each
gene under investigation and RPS11 (40S ribosomal protein
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S11) housekeeping gene was calculated (dCt) and normalized
by subtraction of the Ct values of the samples in the 0 mmHg
group (ddCt). Results were subjected to two-way analysis of
variance (ANOVA) for treatment (pressure level) and length
of incubation (24 or 72 h) for cultures using NCSS (Kaysville,
UT). Fold changes were calculated (as 2–ddCt) for each replicate
and then averaged among samples in each treatment group for
graphing. For IOP experiments, t test or one-way ANOVA
was used where appropriate. Significant differences (p<0.05)
were further explored with Tukey–Kramer post hoc analysis.
Protein levels were normalized to the levels of β-actin
and were subjected to statistical analysis using ANOVA.
Tables were prepared using Microsoft Excel (Microsoft,
Seattle, WA).
RESULTS
Effect of elevated pressure on isolated retinal cell cultures:
Expression levels of C1q, C2, C4, CFH, and CFI mRNA were
not significantly different (ANOVA; p>0.05) in TR-MUL5
cells in cultures subjected to elevated pressure for either 24
or 72 h (data not shown). Levels of C3 mRNA were low and
could not be reliably assessed in the samples analyzed.
Immunoblotting for C1q also did not detect any
significant differences in the protein levels after 24 and 72
hours exposure to elevated pressure (ANOVA; p>0.05) in
TR-MUL5 cell cultures (Figure 2).
Effect of elevated pressure on organotypic retinal cultures:
No significant changes were detected in gross morphology
or retinal cytoarchitecture after culturing either murine or
primate retinal explants for 3 days. The effects of pressure
on mRNA expression of various complement components in
mouse and primate retinal organotypic cultures are presented
in Figure 3 and Figure 4, respectively.

Figure 2. Extracellular complement
component 1, q subcomponent
(C1q) protein levels in Muller cell
line TR-MUL5 cultures subjected
to different pressure levels. Shown
are representative immunoblots
of extracellular C1q levels in
TR-MUL5 cell cultures subjected
to various levels of pressure (0, 15,
30, and 45 mmHg above ambient)
for either (A) 24 or (B) 72 h.
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Figure 3. Real-time reverse transcription polymerase chain reaction
(RT–PCR) analysis of mouse retinal
organotypic cultures subjected to
different pressure levels. RT–PCR
assays were performed to detect
changes in mRNA expression
levels in mouse retinal organotypic
cultures subjected to different
levels of pressure for 24 h (A)
and 72 h (B). Fold changes are
expressed in comparison to the
average mRNA levels in cultures
exposed to ambient atmospheric
pressure (0 mmHg; thus the 0
mmHg group would have a mean
of 1). Error bars represent standard
error of the mean.

Levels of mRNA of complement genes did not differ
across groups with different pressure exposure for either 24
h or 72 h of pressurization (two-way ANOVA comparison
by pressure exposure; p>0.05) for both mouse and primate
retinal explants. In addition, none of the other proteins
studied showed any pressure effect in mouse cultures. Pressure caused a significant effect on GFAP mRNA expression
(ANOVA; p=0.027) in primate retinal organotypic cultures
after 24 h.
mRNA levels of Thy 1, GFAP, C2, and C4b were
significantly affected by time in culture (but not by pressure exposure; two-way ANOVA; p<0.0002, 0.0057, 0.012,
and 0.00006, respectively) in organotypic retinal cultures
from C57BL/6 mice. At the same time, for primate retinas
mRNA levels of Thy1, GFAP, SerpinG1, and CFI were also
significantly affected by time in culture (but not by pressure
exposure; two-way ANOVA; p<0.00001, p<0.005, p<0.00001,
and p=0.028, respectively).
Protein levels of C1q (as determined by immunoblotting) remained unchanged (ANOVA; p>0.05) by exposure to
various pressure levels after 24 and 72 h in both mouse (data
not shown) and monkey (Figure 5A,B) organotypic retinal
cultures. CFH immunoreactive protein also did not show any
significant differences (ANOVA; p>0.05) between primate

retinal organotypic cultures subjected to different pressure
levels for 72 h (Figure 5C).
Effect of elevated intraocular pressure elevation in vivo:
Of the 16 mice injected with microbeads, ten demonstrated
increased IOP during the time of the experiment. Only those
mice were included in the final analysis. Mean (±standard
error of the mean [SEM]) cumulative IOP exposure was
137.66±8.18 mmHg ×days for the eyes injected with microbeads, 106.84±5.42 mmHg*days for contralateral eyes of the
same animals, and 108.39±3.88 mmHg*days for the eyes of
the naïve mice.
Peak (mean±SEM) IOP was 25.12±2.54 mmHg for eyes
injected with microbeads, 18.38±1.19 mmHg for contralateral
eyes, and 15.48±0.55 mmHg for naïve eyes.
Average (mean±SEM) IOP of all mice was
18.72±1.56 mmHg for eyes injected with microbeads, 14.13±0.61 mmHg for contralateral eyes, and
15.48±0.55 mmHg for naïve eyes.
Cumulative IOP exposure for the eyes injected with
microbeads was statistically significantly higher (ANOVA;
p<0.007) compared to nontreated contralateral eyes and
eyes from naïve animals (Tukey–Kramer post hoc analysis;
p<0.05; Figure 6). Microbead-injected eyes also had
144
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Fig u re 4. Real-ti me reverse
transcription polymerase chain
react ion ( RT– PCR) a nalysis
of primate retinal organotypic
cultures subjected to different
pressure levels. RT–PCR assays
were performed to detect changes
in mRNA expression levels in
primate retinal organotypic cultures
subjected to different levels of pressure for 24 h (A) and 72 h (B). Fold
changes are expressed in comparison to the average mRNA levels in
cultures exposed to ambient atmospheric pressure (0 mmHg; thus the
0 mmHg group would have a mean
of 1). Error bars represent standard
error of the mean.

statistically significantly higher peak IOP (ANOVA; p<0.013)
and average IOP (ANOVA; p<0.025) values compared to the
nontreated contralateral and naïve eyes.
mRNA expression levels of the genes studied were
found to be similar in the retinas from the eyes subjected to
increased IOP versus retinas from contralateral eyes (Figure

7A) when normalized to the mRNA levels from the retinas of
naïve animals (t test; p>0.05).
C1q immunoblotting did not reveal any differences in
the levels of C1q protein (ANOVA; p>0.05) between retinas
subjected to IOP elevation, contralateral control retinas of the
same animals, or retinas of naïve mice (Figure 7B).

Figure 5. Complement component
1, q subcomponent (C1q) and
complement factor H (CFH) protein
levels in mouse and primate retinal
organotypic cultures subjected to
different pressure levels. Shown
are quantifications of immunoblotting analysis of protein levels of
C1q in primate organotypic retinal
cultures subjected to different
levels of pressure for either 24 (A)
or 72 (B) hours. Quantification of immunoblotting analysis of CFH protein levels in primate retinal organotypic cultures subjected to
different pressure levels for 72 h are presented in (C). Protein levels are normalized to the average level of the respective protein from cultures
exposed to ambient atmospheric pressure (0 mmHg; thus the 0 mmHg group would have a mean of 1). Error bars represent standard error
of the mean. (ANOVA; p>0.05).
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neuroprotection [30]. Similarly to the CNS, complement is
also locally produced in the eye [5,31]. It has been postulated
that locally produced complement plays a protective role in
this immune-privileged organ [32]. However, in the past few
years, several reports have linked complement with several
degenerative eye conditions—most notably age-related
macular degeneration [33] and glaucoma [4,5,34].

Figure 6. Microbead-injected eyes develop higher intraocular pressure (IOP). Eyes exposed to microbead injections in the anterior
chamber developed significantly higher cumulative IOP (ANOVA;
p<0.0065) compared to the contralateral eyes and eyes of the naive
animals. Error bars represent standard error of the mean, *p<0.05.

DISCUSSION
Circulating complement has traditionally been thought of as
an arm of the innate immune system, charged with opsonizing and, in some instances, lysing invading pathogens.
More recently, it has emerged that complement has often
immunomodulatory functions. It is therefore not surprising
that complement appears to be involved in several systemic
autoimmune conditions [26,27].
Up until the early 1990s, it was not well appreciated
that CNS not only has the capability but actually produces
most, if not all, complement components. Since that time,
complement has been implicated in several neurodegenerative conditions [28,29]. At the same time, recent results have
suggested that certain complement proteins may facilitate

The involvement of complement in glaucomatous RGC
loss and axonal degeneration is intriguing. Complement
upregulation in the DBA/2J model of glaucoma occurs early,
before the pathology becomes apparent, and continues even
after significant RGC loss has occurred [4]. Similar observations were made in a rat glaucomatous model and in human
glaucoma specimens [5]. Proteomic analysis in human tissue
showed upregulation of both C1q and C3 but also the downregulation of CFH in human glaucomatous retina [3].
It has been suggested that complement might have
different roles in glaucomatous pathology based on the stage
of the disease [17]. Early in the disease, deposition of the
complement could be mediating removal of RGC dendritic
synapses [11], thus lowering RGC electrical activation and
promoting their survival. As cell death becomes inevitable
and some of the RGCs start undergoing apoptosis, complement might be promoting clearance of the cell debris and by
doing so attenuate the inflammatory responses [17]. On the
other hand, it was suggested that complement deposited on
RGCs may not only target the compromised cells but also
cause a bystander lysis of healthy RGCs and exacerbate the
pathology [5]. Additionally, deposition of the complement
may in fact activate adjacent glial cells and cause them to
become reactive and start synthesizing various inflammatory mediators, including cytokines and superoxide radicals.

Figure 7. Effect of short-term
microbead-induced intraocular
pressure elevation on the complement system in the retina of
C57BL/6 mice. Short-term (7 days)
microbead-induced intraocular
pressure (IOP) elevation did not
produce changes in either complement component mRNA levels
(A; t test; p>0.05) or complement
component 1, q subcomponent
(C1q) protein (B) expression levels
(ANOVA; p>0.05) in the retinas
of C57BL/6 mice. mRNA and C1q
protein levels are normalized to the average level of the respective gene and C1q protein from retinas of naïve control mice (thus the naïve
control group would have a mean of 1). Error bars represent standard error of the mean.
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Synthesis of these molecules by adjacent astroglial and
microglial cells could further damage RGCs. In fact, glial
cell activation has been recently demonstrated to be one of
the pathological mechanisms that operate in glaucomatous
disease [35,36].
It is clear that the role of the complement system in glaucoma is a complex one. It thus requires careful dissection of
potential factors and mechanisms that could be responsible
for its activation. Given the impact of IOP on glaucoma pathogenesis, we attempted to examine whether pressure elevation
can affect the complement system.
Cell lines are a powerful tool for dissecting responses
of individual components of a complex tissue to different
experimental conditions. In recent years several retinal cell
lines have been established, including a rat Muller cell line
(TR-MUL5) [18,37] and a human Muller cell line (MIO-M1)
[38], among others. Those lines have been extensively used
to understand behavior of particular retinal cell types under
various conditions. For example, Muller cell lines were used
in studies that looked at the effects of excess extracellular
glutamate [39] as well as of osmotic stress [40].
Recent studies have suggested that Muller cells are
capable of producing complement system components and
may regulate complement activation within the retina [41].
In addition, our earlier work [4] has suggested that Muller
cells and astrocytes are responsible for complement production in the retina in glaucoma. In this study, we examined
the effect of pressure elevation on Muller cells by using a
TR-MUL5 cell culture. Similar models have been used in the
past to identify molecular changes that occur in response to
high pressure. For example, they have been used to show that
elastin synthesis by glial cells is affected by high pressure
[42] and that elevated pressure induces apoptosis [43] and
oxidative stress in cultured RGCs [44].
We did not detect any significant changes in the levels
of complement components, at least within the timeframe of
this experiment and for the pressure levels studied. These
pressure levels were selected to represent normal (15 mmHg),
moderately high (30 mmHg), and very high (45 mmHg) pressure levels that can be encountered by retinal cells in vivo.
Other studies that used such an ex vivo system have often
looked at pressure levels that are outside the physiologic range
[43-47]. Although the lack of effect of elevated pressure on
complement expression by Muller cells can be interpreted as
an inherent lack of responsiveness, other potential explanations could be that additional cells or factors are required,
as has been reported for other cell types in the retina [48],
or that immortalized cell lines have lost such a capacity. Yet
another possible explanation is that a longer exposure to the
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elevated pressure is needed to induce detectable upregulation
of complement components. Of course we cannot completely
rule out small changes in complement system expression that
were below the detection limit of our methodology.
In contrast to cell lines, organotypic cultures allow
evaluation of responses of the entire tissue to different
conditions under investigation. At the same time, they retain
much of the flexibility and scalability of an in vitro system.
Retinal organotypic cultures have been used to assess the
regeneration potential of RGCs [49], the effects of stem cell
transplantation [50], glutamate excitotoxicity [51], as well as
the effects of drug treatment [52]. Recently, it has also been
shown that organotypic retinal cultures can be used for gene
transfer studies [53].
In this study we employed retinal organotypic cultures
from mice and monkeys to assess the effects of pressure
elevation. Experiments with murine explants allowed direct
comparison of the results from some of the cell culture
experiments with the rodent cell lines as well as with in vivo
experiments in mice (see below). On the other hand, using
primate tissue allowed us to address potential interspecies
variability. It also allows us to relate the findings to human
disease.
It has been shown that rodent organotypic retinal cultures
can be maintained in culture up to 17 days without significant
alterations in laminar architecture of the retina [20]. Other
groups have observed that organotypic tissue cultures could
be kept morphologically and structurally intact for at least 4
days [53]. In the current study we used a protocol that allows
long survival of the tissue in culture [20]. We used the same
protocol and media for the monkey retinal explants. Under
the same conditions, organotypic cultures from donor postmortem human eyes have been maintained for up to 96 h with
preservation of human retinal architecture and no notable
decrease in thickness/density of the nuclear layers [54]. Inline
with the above reports, we did not observe any morphological
alterations in the retinal tissue for culture periods up to 72 h.
Neither murine nor primate explants exhibited changes
in the expression of complement genes after exposure to
elevated pressure for either 24 or 72 h. Similarly, the levels
of C1q and CFH proteins remained unchanged over the range
of pressures, further supporting the conclusion that shortterm elevation of pressure does not affect locally synthesized
complement in the retina.
It has been suggested that elevation of pressure does
not cause stress to the cells resting on a rigid support to any
appreciable degree; even pressure elevations of 50 mmHg
are calculated to cause relative deformations of cellular
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components of less than 0.005% [55]. Nonetheless, several
studies employing different cell lines resting on a rigid
support that were subjected to different levels of pressure
have documented various biologic responses to pressure
elevation [43,56].
The discrepancy between the lack of substantial cell
deformation and observed major biologic responses to pressure elevation has been puzzling. It has been recently argued
[57] that most of the studies in which biologic response to
pressure were observed have actually been documenting
responses to differences in oxygen (and other gasses) tension
that were not accounted for in the designs of those experiments. Use of a vertical column of medium to exert elevated
pressure hydrostatically on the cells located at the bottom
of the column causes the cells at the bottom to experience
decreased oxygen (and increased CO2) tensions because of
differences in diffusion of gases through variable amounts
of fluid. If oxygen tension were controlled, astrocytes under
different levels of pressure did not show significant differences in migration [57]. Another potential confounding factor
is bottle-to-bottle differences in gas tension of the medium,
which might also contribute to different oxygen (or CO2)
tensions that the cells experience in the incubator atmosphere
[57].
On the other hand, a recent study that looked at mechanosensitive channel TRPV1 in cultured RGC-5 cells using
methodology that eliminates diffusion issues has offered a
potential explanation of how pressure alone could trigger
various biologic responses [58]. It was shown that activation of TRPV1 contributes to the apoptotic cell death of
ganglion cells induced by pressure elevation [58]. The authors
discussed several ways that elevated pressure could bring
about activation of these channels and induce the downstream
apoptotic pathways. In particular, cell membrane compression due to elevated pressure could disrupt the cytoskeletal
scaffolding, and this, in turn, could affect the conductance of
channels sensitive to mechanical tension.
The design of our experiment as well as utilization of an
active pressurization and feedback system similar to the one
used in this study [58] addresses some of the issues mentioned
above when using columns of fluid to affect pressure hydrostatically. First, cell cultures and organotypic retinal cultures
are maintained under ambient pressure in the incubator
overnight before they are subjected to elevated pressure the
following day. This allows equilibration with the incubator
gases and minimizes potential variability of gas tensions in
different bottles of medium. Second, an active pressurization
system eliminates differences that could arise due to oxygen
diffusion through the column of medium because under all
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conditions the column of the medium is the same (and is also
negligible, only around 1–2 mm tall), whereas pressure elevation is achieved by a compressed gaseous mixture above the
medium in the enclosed chamber.
According to Henry’s law, the amount of gas dissolved
in a liquid is directly proportional to the partial pressure of
that gas in equilibrium with the liquid. As such, an increase
in pressure of oxygen in the enclosed chamber in our system
will lead to an increase of the partial pressure of oxygen in
the culture medium. However, those effects are small as the
difference between chambers represents only an approximately 5% variation from atmospheric pressure (atmospheric
pressure can range up to 15% at sea level). Thus, it is most
likely that the difference in gene and/or protein expression
between cultures exposed to different pressure levels is the
direct result of pressure itself.
Similarly, the issue of how IOP causes damage to the
retina and optic nerve has not been resolved. IOP is the pressure inside the eye. As such, it applies a force that acts vertical
to the retina and a tangential strain. As the retina is not a rigid
structure, the pressure drop across the retina is minimal (as
experiments involving simultaneous cannulation of the posterior choroid and vitreous have shown [59]). Although there is
undoubtedly some strain applied to the retina with changing
IOP, scleral expansion (which would allow for force transfer
to the retina by making the surface that the retina occupies
larger) is minimal (less that 5 µm or about 0.007% of the eye
circumference). Thus, if there is an effect of IOP on the retina
itself (rather than the optic nerve), this effect is likely directly
related to the actual pressure that the retina is subjected to.
As such, it is interesting that primate organotypic retinal
cultures showed a pressure-related change in expression of
GFAP. GFAP is upregulated early in response to injury within
the CNS [60] and retina [61,62] and can be thought of as a
marker of tissue “stress.” Despite the fact that GFAP expression is affected by pressure, none of the complement genes
studied showed any change in expression in either cultured
cells or retinas. At the same time, one has to keep in mind
that in the organotypic culture model there is inherent and
unavoidable tissue damage, which may precipitate generalized complement activation that may mask small changes
caused by the pressure level difference. Inspection of the
RT-qPCR dissociation curves from organotypic cultures and
retinas from the in vivo experiments suggests that this is not
the case, but such a possibility cannot be completely excluded.
Despite the appeal of in vitro experiments, it is in vivo
studies that ultimately allow us to answer whether results
from in vitro experiments are relevant to actual biologic
processes occurring in the organism. Inducible models of
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glaucoma in rodents have advantages of precise control of
pathology onset. The recently developed microbead occlusion model has been shown to induce RGC damage in mice
mediated by increased IOP [63]. In this model appreciable
RGC loss could be detected as early as 2 weeks after the
onset of IOP elevation [21]. The experiments described
above examined whether short-term elevation of IOP caused
by microbead injection in the anterior chamber of the eye
leads to upregulation of the complement system in the mouse
retina. The results suggest that IOP elevation for up to 7 days
in C57BL/6 mice does not produce changes in complement
expression for any of the genes studied and in C1q protein
levels. This finding is surprising given the potential role of
complement in the pathogenesis of glaucoma. It is, however,
possible that IOP elevation in these mice was not of sufficient
duration to cause complement upregulation. We are presently studying complement expression in animals exposed to
elevated IOP for longer periods of time.
In the present study, we attempted to investigate the
effect of short-term pressure elevation on complement gene
expression in the retina by using a multifaceted approach
that combined various in vitro and in vivo models. Studies
in TR-MUL5 cell lines did not detect significant changes
in cell responses to elevated pressure for up to 3 days in
culture. Using an in vitro system in which entire retinal tissue
is subjected to elevated pressure, i.e., organotypic retinal
cultures, we similarly did not detect any significant changes
in complement upregulation as a function of elevated pressure
for up to 3 days. Those results were mirrored by the data
from an in vivo model in which we subjected mouse retinas to
experimental IOP elevation for 7 days. Combined, our results
show that short-term exposure to elevated pressure alone
does not dramatically affect complement gene expression in
rodents and in organotypic cultures in primates.
This study was designed to test the null hypothesis that
pressure does not affect complement expression in the retina.
As such, the results of this study cannot be used as proof that
such changes do not occur. To do that, a study with much
higher power testing and an alternative null hypothesis would
be technically needed. However, the absence of changes in
complement activation across all the models employed in the
current study strongly suggests that reported involvement of
the complement system in glaucoma is independent of shortterm changes of IOP. Either long-term elevation in IOP leads
to pronounced cumulative effects of pressure or an additional
stimulus is required to cause complement upregulation and
activation, like the one seen in DBA/2J mice [4], laser-treated
rats [5], or patients having glaucoma [3-5]. Additional studies
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are needed to elucidate the role of complement activation in
glaucoma.
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